(c) 2024 PillSync.com

glipizide tablet film coated extended release

1 INDICATIONS AND USAGE Glipizide extended-release tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablets are a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis. 1.1 Limitations of Use Glipizide extended-release tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

par pharmaceutical, inc.


5 years ago ROUND WHITE C 746 glipizide tablet film coated extended release

ROUND WHITE C 746

16 HOW SUPPLIED/STORAGE AND HANDLING Glipizide Extended-Release Tablets are supplied as 5 mg and 10 mg film-coated, round tablets and imprinted in black as follows: Table 2. Glipizide Extended-Release Tablets Presentations Tablet Strength Tablet Color/ Shape Tablet Markings Package Size NDC Code 5 mg pink, film-coated, round Indentation hole on one side, with ā€œCā€ and ā€œ745ā€ in black on one side and plain on the other side Bottles of 100 NDC 10370-745-01 Bottles of 500 NDC 10370-745-05 10 mg white, film-coated, round Indentation hole on one side, with ā€œCā€ and ā€œ746ā€ in black on one side and plain on the other side Bottles of 100 NDC 10370-746-01 Bottles of 500 NDC 10370-746-05 Store at 20Ā° to 25Ā°C (68Ā° to 77Ā°F) [See USP Controlled Room Temperature]. PROTECT FROM MOISTURE AND HUMIDITY. Dispense in a tight, light-resistant container as defined in the USP. Do not crush.


More pills like ROUND C 746












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site